Article Information
History
- February 19, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Christian Schnier1,
- Aoife McCarthy2,
- Daniel R Morales3,4,
- Ashley Akbari5,
- Reecha Sofat6,7,
- Caroline Dale6,
- Rohan Takhar8,
- Mamas A. Mamas9,
- Kamlesh Khunti10,
- Francesco Zaccardi10,11,
- Cathie LM Sudlow7,12,13,
- Tim Wilkinson13,14,* and
- the CVD-COVID-UK/COVID-IMPACT Consortium
- 1Royal (Dick) School of Veterinary Studies, University of Edinburgh, UK
- 2Edinburgh Medical School, University of Edinburgh, UK
- 3Division of Population Health and Genomics, University of Dundee, Dundee, UK
- 4Department of Public Health, University of Southern Denmark, Odense, Denmark
- 5Swansea University Medical School, Swansea University, Swansea, Wales, UK
- 6Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
- 7British Heart Foundation Data Science Centre, HDR UK, London, UK
- 8Institute of Health Informatics, University College London, London, UK
- 9Keele Cardiovascular Research Group, Keele University, Stoke on Trent, UK
- 10Diabetes Research Centre, University of Leicester, UK
- 11Real World Evidence Unit, University of Leicester, Leicester, UK
- 12Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK
- 13Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
- 14Sunnybrook Research Institute, University of Toronto, Toronto, Canada
- ↵* Corresponding author; email: tim.wilkinson{at}ed.ac.uk
Posted February 19, 2023.
Antipsychotic prescribing and mortality in people with dementia before and during the COVID-19 pandemic: retrospective cohort study
